Specific inhibition of HDAC8 can reduce hypertension by inhibiting arterial remodelling, vasoconstriction and inflammation [108], suggesting that HDAC8 is a regulator of hypertension and a potential therapeutic target. This evidence concerns the gene HDAC8 and hypertensive disorder.